Search Results for: Alzheimer

3183 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
APP and RASL10B amyloid beta (A4) precursor protein RAS-like, family 10, member B
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
APP and POLDIP2 amyloid beta (A4) precursor protein polymerase (DNA-directed), delta interacting protein 2
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
APP and UBE3C amyloid beta (A4) precursor protein ubiquitin protein ligase E3C
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Class I MHC mediated antigen processing & presentation
  • Adaptive Immune System
APP and CTNNB1 amyloid beta (A4) precursor protein catenin (cadherin-associated protein), beta 1, 88kDa
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • APC truncation mutants have impaired AXIN binding
  • misspliced GSK3beta mutants stabilize beta-catenin
  • T41 mutants of beta-catenin aren't phosphorylated
  • TCF7L2 mutants don't bind CTBP
  • truncated APC mutants destabilize the destruction complex
  • Signaling by Wnt
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • deactivation of the beta-catenin transactivating complex
  • APC truncation mutants are not K63 polyubiquitinated
  • disassembly of the destruction complex and recruitment of AXIN to the membrane
  • S37 mutants of beta-catenin aren't phosphorylated
  • Degradation of beta-catenin by the destruction complex
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • RNF mutants show enhanced WNT signaling and proliferation
  • S33 mutants of beta-catenin aren't phosphorylated
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Innate Immune System
  • truncations of AMER1 destabilize the destruction complex
  • CDO in myogenesis
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Cytosolic sensors of pathogen-associated DNA
  • formation of the beta-catenin:TCF transactivating complex
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • AXIN missense mutants destabilize the destruction complex
  • S45 mutants of beta-catenin aren't phosphorylated
  • repression of WNT target genes
  • beta-catenin independent WNT signaling
  • deletions in the AMER1 gene destabilize the destruction complex
  • Ca2+ pathway
  • Myogenesis
  • AMER1 mutants destabilize the destruction complex
  • TCF dependent signaling in response to WNT
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Signaling by WNT in cancer
  • Urea
APP and CTNND1 amyloid beta (A4) precursor protein catenin (cadherin-associated protein), delta 1
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • Cell junction organization
  • Cell-cell junction organization
  • Signaling by VEGF
  • Adherens junctions interactions
  • VEGFR2 mediated vascular permeability
  • VEGFA-VEGFR2 Pathway
APP and CTSB amyloid beta (A4) precursor protein cathepsin B
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • Toll-Like Receptors Cascades
  • Trafficking and processing of endosomal TLR
  • Collagen formation
  • Collagen degradation
  • MHC class II antigen presentation
  • Degradation of the extracellular matrix
  • Assembly of collagen fibrils and other multimeric structures
  • Adaptive Immune System
  • Innate Immune System
  • 2-Aminoethanimidic Acid
  • 3-Amino-4-Oxybenzyl-2-Butanone
  • 3-Methylphenylalanine
  • N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline
  • 2-Pyridinethiol
  • Diphenylacetic Acid
  • N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane
  • N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-
  • N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE
  • BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE
  • METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE
  • N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE
  • N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE
  • N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE
APP and PPP6R2 amyloid beta (A4) precursor protein protein phosphatase 6, regulatory subunit 2
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
APP and CEP57 amyloid beta (A4) precursor protein centrosomal protein 57kDa
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • Organelle biogenesis and maintenance
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Loss of Nlp from mitotic centrosomes
  • G2/M Transition
  • Assembly of the primary cilium
  • Centrosome maturation
  • Regulation of PLK1 Activity at G2/M Transition
  • Mitotic G2-G2/M phases
  • Anchoring of the basal body to the plasma membrane
  • Recruitment of mitotic centrosome proteins and complexes
  • Cell Cycle, Mitotic
APP and GGA1 amyloid beta (A4) precursor protein golgi-associated, gamma adaptin ear containing, ARF binding protein 1
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
APP and HERPUD1 amyloid beta (A4) precursor protein homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • ATF4 activates genes
  • PERK regulates gene expression
  • Unfolded Protein Response (UPR)
APP and USP6NL amyloid beta (A4) precursor protein USP6 N-terminal like
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
APP and CHTOP amyloid beta (A4) precursor protein chromatin target of PRMT1
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
APP and SH3BGRL3 amyloid beta (A4) precursor protein SH3 domain binding glutamate-rich protein like 3
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
APP and SEPT12 amyloid beta (A4) precursor protein septin 12
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
APP and PUS7L amyloid beta (A4) precursor protein pseudouridylate synthase 7 homolog (S. cerevisiae)-like
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
APP and NOS1AP amyloid beta (A4) precursor protein nitric oxide synthase 1 (neuronal) adaptor protein
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
APP and ZNF720 amyloid beta (A4) precursor protein zinc finger protein 720
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
  • Generic Transcription Pathway
APP and ATPAF2 amyloid beta (A4) precursor protein ATP synthase mitochondrial F1 complex assembly factor 2
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
APP and FAM122A amyloid beta (A4) precursor protein family with sequence similarity 122A
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation
APP and CDCA3 amyloid beta (A4) precursor protein cell division cycle associated 3
  • Signaling by GPCR
  • Platelet degranulation
  • Metabolic disorders of biological oxidation enzymes
  • RIP-mediated NFkB activation via ZBP1
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Amyloids
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Peptide ligand-binding receptors
  • Toll Like Receptor 5 (TLR5) Cascade
  • The NLRP3 inflammasome
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Response to elevated platelet cytosolic Ca2+
  • MyD88 dependent cascade initiated on endosome
  • Toll Like Receptor 9 (TLR9) Cascade
  • G alpha (i) signalling events
  • TRIF-mediated TLR3/TLR4 signaling
  • Toll Like Receptor 2 (TLR2) Cascade
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • Platelet activation, signaling and aggregation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • G alpha (q) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • MyD88 cascade initiated on plasma membrane
  • ZBP1(DAI) mediated induction of type I IFNs
  • ECM proteoglycans
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Advanced glycosylation endproduct receptor signaling
  • Innate Immune System
  • Inflammasomes
  • Cytosolic sensors of pathogen-associated DNA
  • MyD88-independent cascade
  • GPCR ligand binding
  • Toll-Like Receptors Cascades
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll Like Receptor 10 (TLR10) Cascade
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • TRAF6 mediated NF-kB activation

Page 28 out of 160 pages